HeartSciences Inc. (HSCS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
HeartSciences Inc. (HSCS) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.2 3 ea029612701ex10-2.htm NOTICE OF GRANT AND RESTRICTED STOCK AWARD AGREEMENT, DATED AS OF JUNE 22, 2026, BETWEEN HEARTSCIENCES AND ANDREW SIMPSON Exhibit 10.2 HEARTSCIENCES INC. NOTICE OF GRANT AND RESTRICTED STOCK AGREEMENT Subject to the terms and conditions of this Not
How this was made
The 30-second read
Why it matters
The filing documents equity compensation (425,000 restricted shares) with vesting scheduled over time and conditioned on a transaction closing, plus employment-based acceleration/forfeiture rules.
Market read
This is a routine SEC compensation disclosure with transaction-conditional vesting mechanics; it does not provide new deal economics or guidance.
What to watch
Acceleration/forfeiture provisions (e.g., termination without just cause triggers full vesting) may matter for internal retention risk, but they are not quantified here and are unlikely to move the stock on their own.
Background
The 8-K includes Item 5.02 compensatory arrangements and an exhibit describing a restricted stock award agreement dated June 22, 2026.
Ticker impact
HeartSciences filed an 8-K granting 425,000 restricted shares to Andrew Simpson with vesting tied to a merger closing and employment conditions.
Likely limited near-term impact; any effect would be indirect via confirmation of ongoing transaction/closing process.
The disclosure is primarily about restricted stock grant and vesting acceleration/forfeiture rules; it does not state new financial guidance, deal value, or revised closing timeline.
Market effects
Minimal; this is company-specific compensation/transaction-conditional vesting rather than a sector catalyst.
None indicated.
None indicated.
Counterpoint
Because vesting is contingent on a “Closing of the Transaction,” the grant could be read as continued progress toward closing, but the filing still lacks any new closing date or revised terms.
Key entities
- CompanyHeartSciences Inc.
Subject of the SEC 8-K; granted restricted stock to an employee with vesting tied to a transaction closing.
- Officer/EmployeeAndrew Simpson
Grantee of 425,000 restricted shares under the company’s equity incentive plan.
